Skip to main content
grasp.study
About
Explore
Pricing
Log in
Try it for free
Back to course
đź‘‹
Welcome to a Grasp lesson
Create a free account
to keep studying and create your own study path.
GLP-1 Receptor Agonist Biology
·
Module 5
Emerging Research: Addiction, Cognition, and Cancer
1
Critically Appraising Alcohol-Use-Disorder Trials
Appraise a randomized alcohol-use-disorder trial by its drinking outcomes, participant selection, and follow-up, without extrapolating its results to every addiction.
2
Reconciling Dementia Risk Associations with Alzheimer’s Treatment Evidence
Reconcile observational dementia-risk associations with randomized Alzheimer's treatment results, including EVOKE and EVOKE+, without treating biomarker changes as proof of cognitive benefit.
3
Evaluating Cancer Risk Evidence and Prevention Claims
Assess a cancer-risk or cancer-prevention claim without conflating rodent thyroid findings, human safety data, and observational associations, accounting for rare events and cancer latency.
4
Evaluating GLP-1 News Claims: Evidence, Uncertainty, and Needed Research
Write a short evidence verdict on a GLP-1 news claim that identifies what is established, what remains uncertain, and what further study would be needed.
End of course,
Back to course
Previous module
Adverse Effects and the Limits of Safety Evidence
Next module